Document is current

Article History

Received: 11 May 2026

Accepted: 18 August 2026

First Online: 1 September 2026

Declarations

Ethics approval and consent to participate: The study was approved by the CHU Liège ethics committee. Signed informed consent was obtained from patients upon their entry into the asthma clinic at CHU Liège. They agreed to the use of their clinical data and the health outcomes they reported in the routine setting for research purposes. All procedures performed in this study involving human participants were conducted in accordance with the Declaration of Helsinki and relevant national regulations.

Consent for publication: Written informed consent has been obtained from the patient to publish this paper.

Competing interests: Outside of this submitted work, RL received unrestricted research grants from GSK, AstraZeneca, Sanofi and Chiesi, lecture or adboard fees from GSK, AZ, Novartis and Sonafi and participation on a data safety monitoring board from AstraZeneca. Outside of this submitted work, FS received grants or contracts from GSK, AstraZeneca, Chiesi and Novartis, consulting fees from GSK, AstraZeneca, Chiesi and Novartis, and lectures for GSK, AstraZeneca, Chiesi and Novartis. The rest of the authors declare that they have no relevant conflicts of interest.